The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.
Related Posts
Health Care Roundup: Market Talk
Merck KGaA, Longboard and more in the latest Market Talks covering the Health Care sector.
Standard General Agrees to Buy Out Bally
Hedge fund Standard General agreed to buy the balance of shares in casino chain Bally’s in a deal that values the firm at about $4.6 […]
Porsche Bruised by Tough Chinese Market, High Supplier Costs
Porsche profits suffered in the first half of the year as sales and deliveries dropped, weighed by a soft performance in China and the high […]